Collectively, these findings suggest that integrating readily available biomarkers such as HALP, FIB-4, and GPR with conventional morphologic features could enhance the stratification of HCC patients prior to liver transplantation and help identify individuals at higher risk for recurrence and mortality. The gene discussed is ALDH18A1; the disease is hepatocellular carcinoma.